MAY 20, 2021 6:30 AM PDT

Why Delaying the 2nd COVID Shot is Paying Off for Some

WRITTEN BY: Tara Fernandez

A new study indicates that delaying the second “booster” dose of the Pfizer-BioNTech COVID vaccine (to 11-12 weeks rather than 3 weeks) increases protective immune responses over threefold in individuals over 80 years old.

“This study further supports a growing body of evidence that the approach taken in the UK for delaying that second dose has really paid off,” explained epidemiologist Gayatri Amirthalingam.

So far, more than 1.41 billion COVID vaccines have been administered globally. Two doses of the  Pfizer, Moderna, and Oxford-AstraZeneca COVID vaccines are required for individuals to build a robust, protective antibody response against SARS-CoV-2. This is the first study demonstrating that delaying the second dose strengthens this immune response, a finding that could inform vaccine scheduling decisions.

Amirthalingam and colleagues tracked antibody responses in 175 vaccinated individuals over the age of 80. The two groups of participants received the booster shot either 3 weeks or 11-12 weeks after the first one. The researchers found that peak antibody levels were around 3.5 times greater in those who waited longer.

While this data is specific to the Pfizer vaccine (one that is currently only available to select countries), follow up studies will need to determine whether similar immune dynamics also apply to delaying the second shot for other vaccines.

For now, maintaining restrictions during the vaccine rollout is important, given that the first dose only provides people with partial immunity to COVID. 

 


Source: Nature.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 26, 2021
Immunology
Can we Stop Multiple Sclerosis Progression?!
JAN 26, 2021
Can we Stop Multiple Sclerosis Progression?!
Multiple sclerosis is known for its progression of symptoms even after a period of complete remission. There is no way o ...
JAN 28, 2021
Neuroscience
Immune Cells Destroy Synapses in Multiple Sclerosis
JAN 28, 2021
Immune Cells Destroy Synapses in Multiple Sclerosis
Researchers from Germany have found that Multiple sclerosis (MS)-associated inflammation in the cerebral cortex destroys ...
FEB 23, 2021
Immunology
Immune Link Explains Why Personality Influences Mortality
FEB 23, 2021
Immune Link Explains Why Personality Influences Mortality
University of Limerick researchers have discovered direct links between the immune system, specific personality traits, ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
MAY 06, 2021
Immunology
COVID Vaccines Don't Protect Everyone
MAY 06, 2021
COVID Vaccines Don't Protect Everyone
New research has revealed that COVID-19 vaccines may not work as effectively in those whose immune systems have been neg ...
JUN 03, 2021
Immunology
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
JUN 03, 2021
Inhalable Anti-COVID Nanobodies Show Promising Results in Hamsters
Nanobodies are small fragments of monoclonal antibodies that from a therapeutic perspective are more stable and cheaper ...
Loading Comments...